We hear it time and again, consuming fat is bad for you, especially if you have prostate cancer. There have been numerous studies that all conclude that your diet should have only limited quantities of saturated fat. MD Anderson recently published an article that showed dietary fat is unhealthy and dangerous when quantities are not [...]
According to a study published April 16, 2008, regular exercise is the best way to manage cancer-related fatigue! Fatigue is a common problem for men with prostate cancer. It is also a common side effect of all the available prostate cancer treatments, both primary and secondary treatments. The most common advice we receive for coping [...]
Many of us, who are dealing with advanced prostate cancer, become understandably concerned about our rising PSA. Given free choice, we all would be much happier if our PSA just disappeared and became undetectable. Granted, a rising PSA is indeed a bad sign, but the rate of rise and how we actually feel is more [...]
The last few days have seen a lot of commotion and celebrating in the prostate cancer world. There have been multiple news stories of an experimental prostate cancer drug, abiraterone, that has been reported to dramatically shrink prostate cancer tumors and extend survival in 70 to 80 percent of men with aggressive prostate cancer. Abiraterone [...]
Studies show more than 90 percent of patients with cancer may experience an increase in the blood's clotting activity, which can lead to a Deep Vein Thrombosis, or DVTs. DVTs can be a life threatening complication which a majority of cancer survivors will face as they wend their way through treatment. DVT occurs when a [...]
Ketoconazole (kee-ta-KOE-na-zol), generic name for Nizoral, is an oral drug approved by the FDA for the use to treat fungal infections. However, it has been shown that higher doses of ketoconazole (800-1200mg/day vs 200-400mg/day) also block the production of both free and bound testosterone. Since high-dose Ketoconazole (HDK) has testosterone lowering effects, operating both on [...]
Oh no, another not so very clear issue for men with prostate cancer has emerged! According to an article written by Tara Parker-Pope in the New York Times, bisphosphonates (i.e. Fosamax), has been reported, in some rare occasions, to actually cause weaker bones that lead to an unusual type of fracture of the femur. Bisphosphonates [...]
Yesterday afternoon Senators Harkin and Specter introduced a landmark supplemental funding bill for the NIH. The Senator's bill proposes providing the National Cancer Institute with an additional $1.2 billion and the rest of the National Institutes of Health with $4 billion for FY 2008. This bill stems from their concern about the inadequate funding for [...]
A short time ago, I asked you to write to your legislators and encourage them to increase the nation's investment in cancer research and early detection programs in the federal government's 2009 budget. This funding is crucial to discovering and delivering the cures that we so desperately need. Thanks to your efforts, both the Senate [...]
According to Philip M. Arlen, M.D., director of the Clinical Research Group for the Laboratory of Tumor Immunology and Biology, Center for Cancer Research, at the National Cancer Institute, "Vaccines, if and when they are approved, can be safely and effectively combined with other therapies, including hormones. There appears to be an advantage in overall [...]
